Reference
Fominykh M, et al. The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis. British Journal of Haematology 178: 645-646, No. 4, Aug 2017. Available from: URL: http://doi.org/10.1111/bjh.14162 - Russia
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1671, 46 (2017). https://doi.org/10.1007/s40278-017-36480-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-36480-4